107 related articles for article (PubMed ID: 1559731)
1. Expression of T6 antigen on keratinocytes in alopecia areata.
Lotti T; Knoepfel B; Zangheri M; Panconesi E
Int J Dermatol; 1992 Feb; 31(2):103-6. PubMed ID: 1559731
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-DR by anagen hair follicles in alopecia areata.
Messenger AG; Bleehen SS
J Invest Dermatol; 1985 Dec; 85(6):569-72. PubMed ID: 2415641
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy.
Bröcker EB; Echternacht-Happle K; Hamm H; Happle R
J Invest Dermatol; 1987 May; 88(5):564-8. PubMed ID: 3471816
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration.
Khoury EL; Price VH; Greenspan JS
J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of Ki-67 antigen in hair follicle of alopecia areata.
van Baar HM; Perret CM; van Vlijmen IM; van de Kerkhof PC; Happle R; Schalkwijk J
Acta Derm Venereol; 1992; 72(3):161-4. PubMed ID: 1357847
[TBL] [Abstract][Full Text] [Related]
6. Increased number of OKT6-positive dendritic cells in the hair follicles of patients with alopecia areata.
Kohchiyama A; Hatamochi A; Ueki H
Dermatologica; 1985; 171(5):327-31. PubMed ID: 3908173
[TBL] [Abstract][Full Text] [Related]
7. Increased HLA-DR+ T-lymphocyte population in peripheral blood of alopecia areata.
Imai R; Miura J; Takamori K; Ogawa H
Clin Exp Dermatol; 1991 May; 16(3):176-80. PubMed ID: 1934567
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors.
Ghersetich I; Campanile G; Lotti T
Int J Dermatol; 1996 Jan; 35(1):28-33. PubMed ID: 8838925
[TBL] [Abstract][Full Text] [Related]
10. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
[TBL] [Abstract][Full Text] [Related]
11. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
Sato-Kawamura M; Aiba S; Tagami H
Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata.
Hamm H; Klemmer S; Kreuzer I; Steijlen PM; Happle R; Bröcker EB
Arch Dermatol Res; 1988; 280(3):179-81. PubMed ID: 3377529
[No Abstract] [Full Text] [Related]
14. Role of cytotoxic T cells in chronic alopecia areata.
Bodemer C; Peuchmaur M; Fraitaig S; Chatenoud L; Brousse N; De Prost Y
J Invest Dermatol; 2000 Jan; 114(1):112-6. PubMed ID: 10620125
[TBL] [Abstract][Full Text] [Related]
15. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to hair follicles in alopecia areata.
Tobin DJ; Orentreich N; Fenton DA; Bystryn JC
J Invest Dermatol; 1994 May; 102(5):721-4. PubMed ID: 8176253
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
Yano S; Nakamura K; Okochi H; Tamaki K
Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic features of alopecia areata: a new look.
Whiting DA
Arch Dermatol; 2003 Dec; 139(12):1555-9. PubMed ID: 14676070
[TBL] [Abstract][Full Text] [Related]
19. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
[TBL] [Abstract][Full Text] [Related]
20. Changes in populations of HLA-DR+CD3+ cells and CD57-CD16+ cells in alopecia areata after corticosteroid therapy.
Imai R; Takamori K; Ogawa H
Dermatology; 1994; 188(2):103-7. PubMed ID: 7511010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
